Financial Data and Key Metrics Changes - Total revenue for Q2 2025 was $80.4 million, down from $164.9 million in Q2 2024, primarily due to the decline in government vertical related to migrant projects [19] - Mobile health revenue decreased to $30.8 million from $116.7 million year-over-year, with approximately $18 million attributed to migrant-related revenues [20] - Medical Transportation Services revenue increased to $49.6 million from $48.2 million year-over-year, reflecting a 7% increase when excluding Colorado's impact [20][21] - Adjusted EBITDA for Q2 2025 was a loss of $6.1 million compared to a profit of $17.2 million in Q2 2024 [21] - Adjusted gross margin for the mobile health segment was 32.5%, down from 35.9% in Q2 2024, but improved from 30.8% in Q1 2025 [21][22] Business Line Data and Key Metrics Changes - The company completed over 176,000 medical transports and more than 28,000 mobile phlebotomy visits in Q2, meeting operational targets [9][10] - The Care Gap Closure Program saw an increase in assigned lives from 900,000 to 1.2 million, indicating growth in patient engagement [11][12] - The medical transportation segment accounted for 62% of total revenue, while mobile health made up the remaining 38% [21] Market Data and Key Metrics Changes - The company is expanding its services in Southern California and anticipates adding services in over a dozen new states by 2026 [10][11] - The demand for proactive healthcare is increasing, particularly in addressing chronic diseases, which presents significant opportunities for the company [9][10] Company Strategy and Development Direction - The company is focused on innovative solutions for payers, providers, and health systems to transform proactive healthcare delivery [6] - There is a strong emphasis on reducing SG&A costs, with an estimated annualized savings of $10 million from workforce reductions [8][24] - The company aims to achieve positive adjusted EBITDA in the latter half of 2026, targeting quarterly revenues in the $80 million to $85 million range [25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong market need for their services and the potential for growth in the payer and provider verticals [6][10] - The company is optimistic about the future, citing a robust pipeline and improved cash flow from operations [26][28] - Management highlighted the importance of technology and AI in enhancing patient engagement and operational efficiency [14][22] Other Important Information - The company celebrated its ten-year anniversary and ten millionth patient interaction, marking significant milestones in its journey [17] - Cash and cash equivalents increased to $128.7 million as of June 30, 2025, up from $103.1 million at the end of Q1 2025 [26][27] - The company repurchased 2.5 million shares for approximately $5.1 million during the quarter, with an extension of the buyback program approved until December 31 [28][29] Q&A Session Summary Question: Why did the increase in Care Gap patients not change revenue and EBITDA guidance? - Management clarified that the increase in patients was from existing contracts and emphasized the need to ramp up field teams to meet demand [31][32] Question: What caused the sequential decline in medical transport revenue? - Management explained that the decline was due to seasonality and not related to negative contract repricing, with higher revenues in Q1 leading to a settling in Q2 [34][35] Question: What is the EBITDA margin for the medical transport business? - Management indicated that the EBITDA margin was in the mid-single digits for the quarter, with a long-term target of double-digit margins [40][41] Question: What percentage of annual revenue will medical transport represent this year? - Management projected that medical transport would account for approximately 60% to 65% of annual revenue, with growth expected in the payer and provider business [42]